Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

539 ARTÍCULOS , VIENDO DEL 271 AL 285

What do Cochrane systematic reviews say about non-pharmacological interventions for treating cognitive decline and dementia?

Vilela VC, Pacheco RL, Latorraca COC, Pachito DV, Riera R.

Sao Paulo Med J. 2017 May-Jun;135(3):309-320. doi: 10.1590/1516-3180.2017.0092060617.

[Role of Mediterranean diet on the prevention of Alzheimer disease]

Miranda A, Gómez-Gaete C, Mennickent S.

Rev Med Chil. 2017 Apr;145(4):501-507. doi: 10.4067/S0034-98872017000400010.

Cognitive Deficits in Patients With Neuropsychiatric Symptoms: A Comparative Study Between Behavioral Variant Frontotemporal Dementia and Primary Psychiatric Disorders

Vijverberg EGB, Schouws S, Meesters PD, Verwijk E, Comijs H, Koene T, Schreuder C, Beekman A, Scheltens P, Stek M, Pijnenburg Y, Dols A.

J Clin Psychiatry. 2017 Sep/Oct;78(8):e940-e946. doi: 10.4088/JCP.16m11019.

Help me, help me

Simard J.

Ann Palliat Med. 2017 Oct;6(4):405-407. doi: 10.21037/apm.2017.06.01.

[Efficacy and tolerance of Memantine monotherapy and combination therapy with Reinhartdt And Sea Cucumber Capsule on agitation in moderate to severe Alzheimer disease]

Yu EY, Liao ZL, Tan YF, Qiu YJ, Zhu JP, Chen Y, Lin SS, Wu MH.

Zhonghua Yi Xue Za Zhi. 2017 Jul 18;97(27):2091-2094. doi: 10.3760/cma.j.issn.0376-2491.2017.27.003.

Catatonia Misdiagnosed as Dementia

Tegin C, Kalayil G, Lippmann S.

J ECT. 2017 Dec;33(4):e40. doi: 10.1097/YCT.0000000000000444.

Tracking Cognitive Decline in Amnestic Mild Cognitive Impairment and Early-Stage Alzheimer Dementia: Mini-Mental State Examination versus Neuropsychological Battery

Kim J, Na HK, Byun J, Shin J, Kim S, Lee BH, Na DL.

Dement Geriatr Cogn Disord. 2017;44(1-2):105-117. doi: 10.1159/000478520. Epub 2017 Aug 3.

A Randomized Controlled Trial Examining the Effect of Acupressure on Agitation and Salivary Cortisol in Nursing Home Residents with Dementia

Kwan RYC, Leung MCP, Lai CKY.

Dement Geriatr Cogn Disord. 2017;44(1-2):92-104. doi: 10.1159/000478739. Epub 2017 Jul 29.

Genome-wide significant, replicated and functional risk variants for Alzheimer's disease

Guo X, Qiu W, Garcia-Milian R, Lin X, Zhang Y, Cao Y, Tan Y, Wang Z, Shi J, Wang J, Liu D, Song L, Xu Y, Wang X, Liu N, Sun T, Zheng J, Luo J, Zhang H, Xu J, Kang L, Ma C, Wang K, Luo X.

J Neural Transm (Vienna). 2017 Nov;124(11):1455-1471. doi: 10.1007/s00702-017-1773-0. Epub 2017 Aug 2.

Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease

Prickaerts J, Heckman PRA, Blokland A.

Expert Opin Investig Drugs. 2017 Sep;26(9):1033-1048. doi: 10.1080/13543784.2017.1364360. Epub 2017 Aug 9.

Is functional mobility an independent mortality risk factor in subjects with dementia?

Mahmoudi R, Novella JL, Manckoundia P, Ahssaini F, Lang PO, Blanchard F, Jolly D, Dramé M.

Maturitas. 2017 Sep;103:65-70. doi: 10.1016/j.maturitas.2017.06.031. Epub 2017 Jul 3.

Cognitive Issues: Decline, Delirium, Depression, Dementia

Harris M.

Nurs Clin North Am. 2017 Sep;52(3):363-374. doi: 10.1016/j.cnur.2017.05.001.

Observational study of vascular dementia in the Spanish elderly population according to type 2 diabetes status: trends in incidence, characteristics and outcomes (2004-2013)

Muñoz-Rivas N, Méndez-Bailón M, Miguel-Yanes JM, Hernández-Barrera V, Miguel-Díez J, Jimenez-Garcia R, López-de-Andrés A.

BMJ Open. 2017 Aug 4;7(8):e016390. doi: 10.1136/bmjopen-2017-016390.

Rollercoaster Blood Pressure: An Alzheimer Disease Risk Factor?

Merkler AE, Iadecola C.

Circulation. 2017 Aug 8;136(6):526-528. doi: 10.1161/CIRCULATIONAHA.117.029618.

Pharmacotherapy for Vascular Cognitive Impairment

Farooq MU, Min J, Goshgarian C, Gorelick PB.

CNS Drugs. 2017 Sep;31(9):759-776. doi: 10.1007/s40263-017-0459-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias